Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: UNIVEC Inc. (UNVCE-Nasdaq)

No earlier versions found for this Subject.

Return to UNIVEC Inc. (UNVCE-Nasdaq)

Univec, Inc. develops, assembles, licenses and markets safety hypodermic syringes designed to
protect the healthcare worker and patient against cross-infection. UNVC also sells other medical
devices and intends to develop other medication delivery systems. For the nine months ended 9/98,
revenues fell 28% to $1.6 million. Net loss applicable to Common totalled $1.1 million vs. a
pro-forma loss of $334 thousand. Results reflect the absence of a $1.7 million supply licensing
agreement.
univec.com
Anybody have info or thoughts on this company??

bcjt